Einstein Experts for Media

Professor, Medicine (Endocrinology)

Director, Institute for Aging Research

Director, Nathan Shock Center of Excellence in the Basic Biology of Aging

Ingeborg and Ira Leon Rennert Chair of Aging Research

Dr. Barzilai discovered the first “longevity gene” in humans. His research established that the gene variant that leads to high HDL, or “good cholesterol,” is linked to healthy aging and extreme longevity. Dr. Barzilai has been profiled by major outlets, including The New York Times, PBS’ “NOVA scienceNow” and National Geographic. read more...

Professor, Department of Medicine (Endocrinology)

Jacob A. and Jeanne E. Barkey Chair in Medicine

Chief, Division of Endocrinology

Director, Fleischer Institute for Diabetes and Metabolism

An expert in diabetes prevention, Dr. Crandall is director of the Diabetes Clinical Trials Unit at Einstein and Montefiore and a principal investigator for several NIH-sponsored clinical trials, including the Diabetes Prevention Program Outcome Study (for which she holds several national leadership positions, including Executive Committee membership), Glycemia Reduction Approaches in Diabetes (GRADE) and the PERL (Preventing Early Renal Loss) study.  read more...

Professor and Chair, Surgery, Einstein and Montefiore Health System

Professor and Chair, Cardiothoracic & Vascular Surgery, Einstein and Montefiore

Co-Director, Montefiore Einstein Center for Heart and Vascular Care

Surgeon-in-Chief, Montefiore

Dr. Michler is a heart surgeon who specializes in complex aortic and mitral valve repair surgery. He is an NIH-funded investigator whose interest in repairing the injured heart has led to clinical trials in cardiac stem cell transplantation. Dr. Michler and his teams have advanced minimally invasive cardiothoracic surgery procedures and surgical robotics. This work led to FDA approval for selective cardiac robotic procedures including mitral valve repair and coronary bypass surgery. read more...

Professor, Biochemistry

Ruth Merns Chair in Biochemistry

Dr. Schramm is a member of the National Academy of Sciences and associate editor of the Journal of the American Chemical Society.  His pioneering work in biochemistry has resulted in powerful new strategies for treating cancer, antibiotic resistance and autoimmune diseases. read more...

Professor, Medicine (Oncology)

Professor, Obstetrics & Gynecology and Women's Health

Associate Director, Clinical Research, Albert Einstein Cancer Center

Associate Chairman, Medical Oncology, Montefiore Einstein Center for Cancer Care

Dr. Sparano is a clinical researcher who develops and evaluates new treatment approaches for  breast cancer, lymphoma, and other cancers, including cancers associated with HIV infection. He also identifies genes that can be used to determine breast cancer prognosis and predict response to treatment – and that may be targeted in cancer as a treatment. He was involved in developing the Oncotype DCIS test, which provides patients with ductal carcinoma in situ of the breast a score that predicts the likelihood of recurrence after surgery, allowing the treatment program to be individualized. read more...